Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 2/2021

Open Access 01-02-2021 | Warfarin

Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar

Authors: Eman Alhmoud, Osama Abdelsamad, Ezeldin Soaly, Rasha El Enany, Hazem Elewa

Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2021

Login to get access

Abstract

Coronavirus Disease 2019 (COVID-19) is a pandemic affecting many countries worldwide. Given the increasing incidence especially in elderly and individuals with comorbid conditions, it is advised by health authorities to stay home if possible, maintain social distancing and stay away from those who are sick or could be infected. Patients with comorbidities especially cardiovascular disease are at higher risk of getting infected with COVID-19 and have worse prognosis. Among efforts to safely manage warfarin patients during this pandemic, we introduced a hospital drive-up anticoagulation testing service. This service can reduce the risk of exposure of anticoagulation patients to COVID-19 by reducing the contact time with the different personnel at the hospital and by maintaining those patients at a safe distance from others
Literature
4.
go back to reference Bader L, Mahfouz A, Kasem M, Mohammed S, Alsaadi S, Abdelsamad O, Elenani R, Soaly E, Elzouki A, Rizk N, Khalifa S, Shahin MH, Cavallari LH, Mraiche F, Elewa H (2020) The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population. Pharmacogenomics J 20(2):277–284. https://doi.org/10.1038/s41397-019-0116-yCrossRefPubMed Bader L, Mahfouz A, Kasem M, Mohammed S, Alsaadi S, Abdelsamad O, Elenani R, Soaly E, Elzouki A, Rizk N, Khalifa S, Shahin MH, Cavallari LH, Mraiche F, Elewa H (2020) The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population. Pharmacogenomics J 20(2):277–284. https://​doi.​org/​10.​1038/​s41397-019-0116-yCrossRefPubMed
5.
go back to reference Elewa H, AbdelSamad O, Elmubark A, Al-Taweel H, Mohamed A, Kheir N, Mohamed Ibrahim M, Awaisu A (2016) The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes. J Clin Pharm Ther 41(4):403–408CrossRefPubMed Elewa H, AbdelSamad O, Elmubark A, Al-Taweel H, Mohamed A, Kheir N, Mohamed Ibrahim M, Awaisu A (2016) The first pharmacist-managed anticoagulation clinic under a collaborative practice agreement in Qatar: clinical and patient-oriented outcomes. J Clin Pharm Ther 41(4):403–408CrossRefPubMed
6.
go back to reference Anticoagulation Forum (2020) Management of warfarin patients who have difficulty getting INR testing during COVID-19 Pandemic Anticoagulation Forum (2020) Management of warfarin patients who have difficulty getting INR testing during COVID-19 Pandemic
Metadata
Title
Anticoagulation clinic drive-up service during COVID-19 pandemic in Qatar
Authors
Eman Alhmoud
Osama Abdelsamad
Ezeldin Soaly
Rasha El Enany
Hazem Elewa
Publication date
01-02-2021
Publisher
Springer US
Keywords
Warfarin
COVID-19
Published in
Journal of Thrombosis and Thrombolysis / Issue 2/2021
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-020-02206-4

Other articles of this Issue 2/2021

Journal of Thrombosis and Thrombolysis 2/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine